Koru Medical Systems, INC Form 4 insider transactions

KORU Medical Systems Director Matin Shahriar acquired 2,581 shares of common stock at $5.81 per share, increasing direct beneficial ownership to 94,101 shares.

KORU Medical Systems Director Robert Cascella reported the acquisition of 2,581 shares of common stock at $5.81 per share, effective January 2, 2026, under a pre-arranged trading plan.

KORU Medical Systems Director Donna French acquired 2,581 shares of common stock at $5.81 per share, increasing her beneficial ownership to 91,471 shares.

KORU Medical Systems Director Edward Wholihan acquired 2,581 shares of common stock at $5.81 per share, increasing his direct beneficial ownership to 44,269 shares.

KORU Medical Systems' Chairman of the Board, R. John Fletcher, acquired 3,872 shares of common stock at $5.81 per share.

Horton Capital Partners Fund, L.P. transferred 41,000 KORU Medical Systems common shares to limited partners for no consideration.

KORU Medical Systems President and CEO Linda M Tharby acquired 29,463 shares of common stock on October 16, 2025, as part of her 2024 annual bonus.

KORU Medical Systems Director Edward Wholihan has a pre-planned acquisition of 3,916 shares of common stock at $3.83 per share, scheduled for October 2, 2025, which will increase his direct beneficial ownership to 41,688 shares.

KORU Medical Systems Director Matin Shahriar acquired 3,916 shares of common stock at $3.83 per share, increasing direct ownership to 91,520 shares.

KORU Medical Systems Director Donna French acquired 3,916 shares of common stock at $3.83 per share, increasing her beneficial ownership to 88,890 shares.

KORU Medical Systems' Chairman of the Board, R. John Fletcher, acquired 5,874 shares of common stock at $3.83 per share.

KORU Medical Systems Director Robert Cascella acquired 3,916 shares of common stock at $3.83 per share, increasing his direct beneficial ownership.

Joseph M. Manko, Jr., a Director and 10% owner of KORU Medical Systems, Inc., acquired 3,916 shares of common stock as compensation for his board service.

KORU Medical Systems' President and CEO, Linda M. Tharby, received significant equity awards including restricted stock units and stock options as part of the company's 2025 Long-Term Incentive Program.

KORU Medical Systems' Chief Operating Officer, Christopher Pazdan, was granted substantial equity awards, including restricted stock units and stock options, as part of the company's 2025 Long-Term Incentive Program.

KORU Medical Systems' Chief Financial Officer, Thomas Adams, was granted a substantial package of restricted stock units and stock options as part of the company's 2025 Long-Term Incentive Program.

KORU Medical Systems' Chief Commercial Officer, Adam R. Kalbermatten, received 300,000 restricted shares and options for 600,000 common shares as an employment inducement.

Robert Cascella, a Director at KORU Medical Systems, Inc., has acquired 4,189 shares of common stock, increasing his beneficial ownership to 84,615 shares.

Edward Wholihan, a Director at KORU Medical Systems, Inc., has acquired 4,189 shares of common stock at a price of $3.58 per share, executed under a Rule 10b5-1(c) plan.

KORU Medical Systems, Inc. Director Matin Shahriar acquired 4,189 shares of common stock at $3.58 per share, increasing his direct beneficial ownership to 87,604 shares.

KORU Medical Systems Director Donna French has acquired 4,189 shares of common stock at $33.58 per share, increasing her direct beneficial ownership to 84,974 shares.

KORU Medical Systems' Chairman of the Board, R. John Fletcher, acquired 6,284 shares of common stock at $3.58 per share, increasing his total beneficial ownership to 211,846 shares.

KORU Medical Systems, Inc. granted 4,189 shares of common stock to Horton Capital Partners Fund, LP, linked to Director Joseph M. Manko, Jr.'s service for the quarter ended June 30, 2025.

Horton Capital Partners Fund, L.P. distributed 14,317 shares of KORU Medical Systems common stock to its limited partners on May 20, 2025.

Linda Tharby, CEO of KORU Medical Systems, reports disposition of shares to cover tax obligations upon vesting of restricted stock.

Director Shahriar Matin of KORU Medical Systems, Inc. reports acquisition of 5,870 shares of common stock at $2.56 per share on April 2, 2025.

Director Edward Wholihan of KORU Medical Systems reports acquiring 5,870 shares of common stock at $2.56 per share.

Director Donna French of KORU Medical Systems, Inc. reports acquiring 5,870 shares of common stock at $2.56 per share on April 2, 2025, bringing her total holdings to 80,785 shares.

Director John Fletcher reports acquiring 8,806 shares of Koru Medical Systems at $2.56 per share, bringing his total holdings to 205,562 shares.

Director Robert Cascella acquired 5,870 shares of KORU Medical Systems at $2.56 per share on April 2, 2025, and now beneficially owns 80,426 shares.